Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
60.17
-0.47 (-0.78%)
At close: Oct 7, 2025, 4:00 PM EDT
60.00
-0.17 (-0.28%)
After-hours: Oct 7, 2025, 6:43 PM EDT

Cytokinetics Stock Forecast

Stock Price Forecast

The 15 analysts that cover Cytokinetics stock have a consensus rating of "Buy" and an average price target of $76.73, which forecasts a 27.52% increase in the stock price over the next year. The lowest target is $41 and the highest is $120.

Price Target: $76.73 (+27.52%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$41$76.73$80$120
Change-31.86%+27.52%+32.96%+99.43%

Analyst Ratings

The average analyst rating for Cytokinetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy644455
Buy777799
Hold333322
Sell000000
Strong Sell000000
Total161414141616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$71$82
BuyMaintains$71$82+36.28%Oct 6, 2025
B of A Securities
B of A Securities
Hold
Maintains
$52$56
HoldMaintains$52$56-6.93%Oct 2, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$120
Strong BuyReiterates$120+99.43%Sep 29, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$74$80
Strong BuyMaintains$74$80+32.96%Sep 22, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$120
Strong BuyReiterates$120+99.43%Sep 22, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
85.65M
from 18.47M
Increased by 363.61%
Revenue Next Year
140.53M
from 85.65M
Increased by 64.08%
EPS This Year
-5.73
from -5.26
EPS Next Year
-5.80
from -5.73
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
55.83M70.43M94.59M7.53M18.47M85.65M140.53M
Revenue Growth
107.79%26.15%34.31%-92.04%145.34%363.61%64.08%
EPS
-1.97-2.80-4.33-5.45-5.26-5.73-5.80
EPS Growth
-------
Forward PE
-------
No. Analysts
-----2220
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High161.5M245.7M
Avg85.6M140.5M
Low66.6M49.0M

Revenue Growth

Revenue Growth20252026202720282029
High
774.3%
186.9%
Avg
363.6%
64.1%
Low
260.7%
-42.8%

EPS Forecast

EPS20252026202720282029
High-5.20-4.29
Avg-5.73-5.80
Low-6.19-7.07

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.